It is part of an international consortium working on the project which will prioritise short-course TB preventive therapy for people living with HIV and children under five years old, and subsequently all those in close contact with TB patients in 12 high-burden countries. These are South Africa, Ghana and Mozambique, Brazil, Ethiopia, Kenya, Tanzania, Malawi, Zimbabwe, India, Cambodia and Indonesia, which represent 50 percent of the global TB burden.